VTRS
Viatris Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$18.48
+0.16%Forward multiples
Based on analyst estimates
- P/E forward
- 7.04x
- P/E 2026E
- 7.32x
- P/E 2027E
- 6.86x
- P/E 2028E
- 6.42x
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.49x
- Price / sales
- 1.44x
- Price / cash flow
- 9.11x
Enterprise value
- Enterprise value
- $33.3B
- EV / sales
- 2.26x
- EV / EBITDA
- 12.27x
- EV / EBIT
- -381.92x
- Market cap
- $21.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026